Hermann A. M. Mucke

Dr. Hermann A.M. Mucke, who was born in 1955 and holds a Ph.D. in biochemistry from the University of Vienna (Austria), spent 17 years in academia and in various positions in the pharmaceutical industry before the year 2000 when he founded H.M. Pharma Consultancy (www.hmpharmacon.com), an Austrian-based enterprise providing strategic advice and tailored services to the life science industry with a strong focus on all aspects of drug repurposing. Dr. Mucke is an accomplished scientist, science author, patent analyst and R&D manager who had a strong role in the repurposing of several drugs during the past 15 years. He has founded, and is managing, LinkedIn discussion group on drug repurposing with 500+ members. Dr. Mucke is the editor of the Drug Repurposing Special Issues of ASSAY and Drug Development Technologies; an editorial board member and regular author of several scientific journals, such as the Pharmaceutical Patent Analyst, and serves on several corporate scientific advisory boards. Among many other market and technology analyses, Dr. Mucke is the author of “Drug Repositioning: Extracting added value from prior R&D investments”, published by Insight Pharma Reports.